Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 89, Issue 5, 2013, Pages 305-311

  Daak, Ahmed A ^a,d   Ghebremeskel, Kebreab ^a   Mariniello, Katia ^a   Attallah, Bakhita ^b   Clough, Peter ^c   Elbashir, Mustafa I ^d  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^b Sickle Cell Referral Clinic   (Sudan)

^c Efamol Limited   (Canada)

^d UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

Antioxidant enzymes; Omega 3 fatty acids; Oxidative stress; Sickle cell disease; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; COPPER ZINC SUPEROXIDE DISMUTASE; DOCOSAHEXAENOIC ACID; GLUTATHIONE PEROXIDASE 1; HAPTOGLOBIN; HEMOGLOBIN; ICOSAPENTAENOIC ACID; LACTATE DEHYDROGENASE; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PLACEBO; RETINOL;

ADOLESCENT; CHILD; CONTROLLED STUDY; HEMATOCRIT; HOMOZYGOTE; HUMAN; INTRAVASCULAR HEMOLYSIS; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MULTICENTER STUDY; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SICKLE CELL ANEMIA; THROMBOCYTE COUNT; VITAMIN BLOOD LEVEL;

HELIANTHUS;

ANTIOXIDANT ENZYMES; OMEGA-3 FATTY ACIDS; OXIDATIVE STRESS; SICKLE CELL DISEASE; VITAMIN E;

ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD VESSELS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FEMALE; HEMOLYSIS; HOMOZYGOTE; HUMANS; MALE; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; SUPEROXIDE DISMUTASE; VITAMIN E;

EID: 84886949856     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.09.006     Document Type: Article

References (76)

1. Serjeant G.R., Serjeant.B.E. Sickle Cell Disease 2001, Oxford University Press, Oxford, UK. 3rd ed.
2. Rees D.C., Williams T.N., Gladwin M.T. Sickle-cell disease. Lancet 2010, 376:2018-2023.
3. Ballas S.K, Lieff S., Benjamin L.J., et al. Investigators, comprehensive sickle cell centers. Definitions of the phenotypic manifestations of sickle cell disease. Am. J. Hematol. 2010, 85:6-13.
4. Kaul D.K., Fabry M.E., Nagel.R.L. The pathophysiology of vascular obstruction in the sickle syndromes. Blood Rev. 1996, 10:29-44.
5. Hebbel R.P., Morgan W.T., Eaton J.W., Hedlund B.E. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc. Natl. Acad. Sci. USA 1988, 85:237-241.
6. Hebbel R.P. The sickle erythrocyte in double jeopardy: autoxidation and iron decompartmentalization. Semin. Hematol 1990, 27:51-69.
7. Chiang E.Y., Frenette P.S. Sickle cell vaso-occlusion. Hematol. Oncol. Clin. North Am. 2005, 19:771-784.
8. Sears D.A., Luthra.M.G. Membrane-bound hemoglobin in the erythrocytes of sickle cell anaemia. J. Lab. Clin. Med. 1983, 102:694-698.
9. Kuross S.A., Rank B.H., Hebbel R.P. Excess heme in sickle erythrocyte inside-out membranes: possible role in thiol oxidation. Blood 1988, 71:876-882.
10. Hebbel R.P., Eaton J.W., Balasingam M., Steinberg M.H. Spontaneous oxygen radical generation by sickle erythrocytes. J. Clin. Invest. 1982, 70:1253-1259.
11. Hebbel R.P. Auto-oxidation and a membrane-associated 'Fenton reagent': a possible explanation for development of membrane lesions in sickle erythrocytes. Clin. Haematol. 1985, 14:129-140.
12. Repka T., Hebbel R.P. Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents. Blood 1991, 78:2753-2758.
13. Nur E., Biemond B.J., Otten H.M., Brandjes D.P., et al. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am. J. Hematol. 2011, 86:484-489.
14. Chirico E.N., Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life 2012, 64:72-80.
15. Nagel R.L, Fabry.M.E. The panoply of animal models of sickle cell anaemia. Br. J. Haematol. 2001, 112:19-25.
16. Hundekar P.S., Suryakar A.N., Karnik A.C., Katkam R.V., Joshi N.G., Ghone R.A. Level of nitric oxide and antioxidant vitamins in sickle cell anaemia patients. Indian. Physiol. Pharmacol. 2012, 56:25-129.
17. De Franceschi L. Pathophysiology of sickle cell disease and new drugs for the treatment. Mediterr. J. Hematol. Infect. Dis. 2009, 20:e2009024.
18. Tomer A., Kasey S., Connor W.E., et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb. Haemost. 2011, 85:966-974.
19. Okpala I., Ibegbulam O., Duru A., et al. Pilot study of omega 3 fatty acid supplement in sickle cell disease. APMIS 2011, 19:442-448.
20. Daak A.A., Ghebremeskel K., Hassan Z., Attallah B., Azan H.H., Elbashir M.I., Crawford M. Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anaemia: randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 2013, 97:37-44.
21. Mas E., Woodman R.J, Burke V., Puddey I.B., Beilin L.J., Durand T, Mori.T.A. The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: results from two placebo-controlled interventions. Free Radic. Res. 2010, 44:983-990.
22. Mori T.A. Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation. Redox. Rep. 2004, 9:193-197.
23. Lagarde M., Calzada C., Guichardant M., Véricel E.E. Dose-effect and metabolism of docosahexaenoic acid: pathophysiological relevance in blood platelets. Prostaglandins Leukot. Essent. Fatty Acids. 2013, 88:49-52.
24. Calzada C., Colas R., Guillot N., Guichardant M., Laville M., Véricel E., Lagarde M. Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men. Atherosclerosis 2010, 208:467-472.
25. Patten A.R., Brocardo P.S., Christie.B.R. Omega-3 supplementation can restore glutathione levels and prevent oxidative damage caused by prenatal ethanol exposure. J. Nutr. Biochem. 2013, 24:760-769.
26. Khan M.W., Priyamvada S., Khan S.A., Khan S., Naqshbandi A., Yusufi A.N. Protective effect of ω-3 polyunsaturated fatty acids on L-arginine-induced nephrotoxicity and oxidative damage in rat kidney. Hum. Exp. Toxicol. 2012, 31:1022-1034.
27. Dubey P., Jayasooriya A.P., Cheema S.K. Fish oil induced hyperlipidemia and oxidative stress in BioF1B hamsters is attenuated by elderberry extract. Appl. Physiol. Nutr. Metab 2012, 37:472-479.
28. Nowak J.Z. Oxidative stress, polyunsaturated fatty acids-derived oxidation products and bisretinoids as potential inducers of CNS diseases: focus on age-related macular degeneration. Pharmacol. Rep 2013, 65:288-304.
29. Catalá A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 2009, 157:1-11.
30. Tsuduki T., Honma T., Nakagawa K., Ikeda I., Miyazawa.T. Long-term intake of fish oil increases oxidative stress and decreases lifespan in senescence-accelerated mice. Nutrition 2011, 27:334-337.
31. McAnulty S.R., Nieman D.C., Fox-Rabinovich M., Duran V., McAnulty L.S., Henson D.A., Jin F F., Landram M.J. Effect of n-3 fatty acids and antioxidants on oxidative stress after exercise. Med. Sci. Sports Exerc. 2010, 42:1704-1711.
32. Garrido A, Garrido F., Guerra R., Valenzuela A. A. Ingestion of high doses of fish oil increases the susceptibility of cellular membranes to the induction of oxidative stress. Lipids 1989, 24:833-835.
33. Budowski P The omega-3 fatty acid peroxidation paradox. Redox. Rep 1996, 2:75-77.
34. Guillot N., Caillet E., Laville M., Calzada C., Lagarde M., Véricel E. Increasing intakes of the long-chain omega-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J 2009, 23:2909-2916.
35. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem 1957, 226:497-509.
36. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
37. Maier C.M., Chan P.H. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 2002, 8:323-334.
38. Walters M.C., Hardy K., Edward S., et al. Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease. Biol. Blood Marrow Transplant 2010, 16:263-272.
39. Michlitsch J.G., Walters M.C. Recent Advances in Bone Marrow Transplantation in Hemoglobinopathies. Curr. Mol. Med. 2008, 8:675-689.
40. Pestina T.I., Hargrove P.W., Jay D, Gray J.T., Boyd K.M., Persons D.A. Correction of murine sickle cell disease using γ-Globin lentiviral vectors to mediate high-level expression of fetal hemoglobin. Mol. Ther. 2009, 17:245-252.
41. Biffi A., Cesani M. Human hematopoietic stem cells in gene therapy: pre-clinical and clinical issues. Curr. Gene Ther. 2008, 8:135-146.
42. D. A. Persons. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders Hematology. Am. Soc. Hematol. Educ. Program. 2009 (2009) 690-697.
43. Sankaran V.G. Targeted Therapeutic Strategies for Fetal Hemoglobin Induction. Hematology Am. Soc. Hematol. Educ. Program 2011, 2011:459-465.
44. Wang W.C., Ware R.E., Miller S.T., et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 2011, 377:1663-1672.
45. Raghupathy R., Billett H.H. Promising Therapies in Sickle Cell Disease. Cardiovasc. Hematol. Disord. Drug Targets 2009, 9:1-8.
46. Strouse J.J., Heeney M.M. Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children. Pediatr. Blood Cancer 2012, 59:365-371.
47. Lukusa A.K., Vermyln C. Use of hydroxyurea from childhood to adult age in sickle cell disease: semen analysis. Hematologica 2008, 93:e67.
48. Berthaut I., Guignedoux G., Kirsch-Noir F., et al. Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males. Hematologica 2008, 93:988-993.
49. Essien E.U. Plasma levels of retinol, ascorbic acid and alpha-tocopherol in sickle cell anaemia. Cent. Afr. J. Med. 1995, 41:48-50.
50. Amer J., Ghoti H., Rachmilewitz E., Koren A., Levin C., Fibach E. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br. J. Haematol. 2006, 132:108-113.
51. Hasanato R.M. Zinc and antioxidant vitamin deficiency in patients with severe sickle cell anaemia. Ann. Saudi Med 2006, 26:17-21.
52. Ren H., Ghebremeskel K., Okpala I., Lee A., Ibegbulam O., Crawford M. Patients with sickle cell disease have reduced blood antioxidant protection. Int. J. Vitam. Nutr. Res. 2008, 78:139-147.
53. Das S.K., Nair R.C. Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Br. J. Haematol. 1980, 44:87-92.
54. Chiu D., Vichinsky E., Yee M., Kleman K, Lubin B. Peroxidation, vitamin E, and sickle cell anaemia. Ann. N. Y. Acad. Sci. 1982, 393:323-335.
55. Natta C.L., Chen L.C., Chow C.K. Selenium and glutathione peroxidase levels in sickle cell anaemia. Acta. Haematol. 1980, 83:130-132.
56. Muskiet F.A., Muskiet F.D., Meiborg G., Schermer J.G. Supplementation of patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean oil, and fish oil. Am. J. Clin. Nutr. 1991, 54:736-744.
57. Gbenebitse S., Jaja S.I., Kehinde M.O. Effect of changes in plasma vitamin E level of vascular responses and lipid peroxidation in sickle cell anaemia subjects. Niger Postgrad. Med. J. 2005, 12:81-84.
58. Jaja S.I., Aigbe P.E., Gbenebitse S., Temiye E.O. Changes in erythrocytes following supplementation with alpha-tocopherol in children suffering from sickle cell anaemia. Niger Postgrad. Med. J. 2005, 12:110-114.
59. Huang H.Y., Appel L.J., Croft C.D., et al. Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial. Am. J. Clin. Nutr. 2002, 76:549-555.
60. Skouroliakou M., Konstantinou D., Koutri K., et al. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur. J. Clin. Nutr. 2010, 64:940-947.
61. Berlin E., Bhathena S.J., Judd J.T., et al. Omega-3 fatty acid supplementation stimulates alpha-tocopherol incorporation in erythrocyte membranes in adult men. Ann. N. Y. Acad. Sci. 1992, 669:322-340.
62. Véricel E., Calzada C., Chapuy P., Lagarde M. The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis 1999, 147:187-192.
63. Croset M., Véricel E., Rigaud M., Hanss M., Courpron P., Dechavanne M., Lagarde M. Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid. Thromb. Res. 1990, 57:1-12.
64. Beretta L., Gerli G.C., Ferraresi R., et al. Antioxidant system in sickle red cells. Acta. Haematol. 1983, 70:194-197.
65. Manfredini V., Lazzaretti L.L., Griebeler I.H., et al. Blood antioxidant parameters in sickle cell anaemia patients in steady state. J. Natl. Med. Assoc. 2008, 100:897-902.
66. Sharma S., Dewald O., Adrogue J., et al. Induction of antioxidant gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species. Free Radic. Biol. Med. 2006, 40:2223-2231.
67. Black A.T., Gray J.P., Shakarjian M.O., et al. Increased oxidative stress and antioxidant expression in mouse keratinocytes following exposure to paraquat. Toxicol. Appl. Pharmacol. 2008, 231:384-392.
68. Wang Q., Sun Y., Ma A., Li Y., Han X., Liang H. Effects of vitamin E on plasma lipid status and oxidative stress in Chinese women with metabolic syndrome. Int. J. Vitam. Nutr. Res. 2010, 80:178-187.
69. Abd Hamid N.A., Hasrul M.A., Ruzanna R.J., et al. Effect of vitamin E (Tri E(R)) on antioxidant enzymes and DNA damage in rats following eight weeks exercise. Nutr. J. 2011, 10:1-7.
70. Ballas S.K., Marcolina M.J. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anaemia. Transfusion 2006, 46:105-110.
71. Akinsheye I., Klings E.S. Sickle cell anaemia and vascular dysfunction: the nitric oxide connection. J. Cell. Physiol. 2010, 224:620-625.
72. Krajewski M.L., Hsu L.L., Gladwin M.T. The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H4-H7.
73. Fibach E., Rachmilewitz E. The role of hemolytic anemia. Curr. Mol. Med. 2008, 8:609-619.
74. Wood K.C., Granger D.N. Sickle cell disease: role of reactive oxygen and nitrogen. Clin. Exp. Pharmacol. Physiol. 2007, 34:926-932.
75. Kato G.J., McGowan V., Machado R.F., et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006, 107:2279-2285.
76. Kupesize A., Celmeli G., Dogan S., Antmen B., Aslan M. The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease. Free Radic. Res. 2012, 46:883-890.